These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 23819347)

  • 1. [Aspirin resistance candidate genes and their association with the risk of fatal cardiovascular events].
    Grinshtein YI; Kosinova AA; Grinshtein IY
    Ter Arkh; 2013; 85(5):95-100. PubMed ID: 23819347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aspirin resistance detected with aggregometry cannot be explained by cyclooxygenase activity: involvement of other signaling pathway(s) in cardiovascular events of aspirin-treated patients.
    Ohmori T; Yatomi Y; Nonaka T; Kobayashi Y; Madoiwa S; Mimuro J; Ozaki Y; Sakata Y
    J Thromb Haemost; 2006 Jun; 4(6):1271-8. PubMed ID: 16706971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of genetic polymorphisms on platelet function and aspirin resistance.
    Pamukcu B; Oflaz H; Onur I; Hancer V; Yavuz S; Nisanci Y
    Blood Coagul Fibrinolysis; 2010 Jan; 21(1):53-6. PubMed ID: 19923980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenetics of the antiplatelet effect of aspirin.
    Würtz M; Kristensen SD; Hvas AM; Grove EL
    Curr Pharm Des; 2012; 18(33):5294-308. PubMed ID: 22724416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The genetics of aspirin resistance.
    Goodman T; Sharma P; Ferro A
    Int J Clin Pract; 2007 May; 61(5):826-34. PubMed ID: 17391325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenetics of aspirin resistance: a comprehensive systematic review.
    Goodman T; Ferro A; Sharma P
    Br J Clin Pharmacol; 2008 Aug; 66(2):222-32. PubMed ID: 18429969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency of genetic polymorphisms of COX1, GPIIIa and P2Y1 in a Chinese population and association with attenuated response to aspirin.
    Li Q; Chen BL; Ozdemir V; Ji W; Mao YM; Wang LC; Lei HP; Fan L; Zhang W; Liu J; Zhou HH
    Pharmacogenomics; 2007 Jun; 8(6):577-86. PubMed ID: 17559347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variable platelet response to aspirin and clopidogrel in atherothrombotic disease.
    Maree AO; Fitzgerald DJ
    Circulation; 2007 Apr; 115(16):2196-207. PubMed ID: 17452618
    [No Abstract]   [Full Text] [Related]  

  • 9. The C50T polymorphism of the cyclooxygenase-1 gene and the risk of thrombotic events during low-dose therapy with acetyl salicylic acid.
    Clappers N; van Oijen MG; Sundaresan S; Brouwer MA; Te Morsche RH; Keuper W; Peters WH; Drenth JP; Verheugt FW
    Thromb Haemost; 2008 Jul; 100(1):70-5. PubMed ID: 18612540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspirin resistance and a single gene.
    Jefferson BK; Foster JH; McCarthy JJ; Ginsburg G; Parker A; Kottke-Marchant K; Topol EJ
    Am J Cardiol; 2005 Mar; 95(6):805-8. PubMed ID: 15757620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Aspirin resistance 2003: a review of the literature].
    Christiaens L; Macchi L
    Arch Mal Coeur Vaiss; 2004 Apr; 97(4):320-6. PubMed ID: 15182075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The concept of aspirin "resistance": mechanisms and clinical relevance].
    Reny JL; Bonvini RF; Barazer I; Berdagué P; de Moerloose P; Schved JF; Gris JC; Fontana P
    Rev Med Interne; 2009 Dec; 30(12):1020-9. PubMed ID: 19595490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aspirin resistance.
    Tran HA; Anand SS; Hankey GJ; Eikelboom JW
    Thromb Res; 2007; 120(3):337-46. PubMed ID: 17241655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspirin resistance: current concepts.
    Mason PJ; Freedman JE; Jacobs AK
    Rev Cardiovasc Med; 2004; 5(3):156-63. PubMed ID: 15346099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical implications of aspirin resistance.
    Patel D; Moonis M
    Expert Rev Cardiovasc Ther; 2007 Sep; 5(5):969-75. PubMed ID: 17867925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of association between aspirin responsiveness and seven candidate gene haplotypes in patients with symptomatic vascular disease.
    Kunicki TJ; Williams SA; Nugent DJ; Harrison P; Segal HC; Syed A; Rothwell PM
    Thromb Haemost; 2009 Jan; 101(1):123-33. PubMed ID: 19132198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The genetics of antiplatelet drug resistance.
    Feher G; Feher A; Pusch G; Lupkovics G; Szapary L; Papp E
    Clin Genet; 2009 Jan; 75(1):1-18. PubMed ID: 19067731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laboratory detection of 'aspirin resistance': what test should we use (if any)?
    Cattaneo M
    Eur Heart J; 2007 Jul; 28(14):1673-5. PubMed ID: 17586540
    [No Abstract]   [Full Text] [Related]  

  • 19. Genetic determinants of response to aspirin: appraisal of 4 candidate genes.
    Lordkipanidzé M; Diodati JG; Palisaitis DA; Schampaert E; Turgeon J; Pharand C
    Thromb Res; 2011 Jul; 128(1):47-53. PubMed ID: 21429568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advance in antiplatelet therapy: the mechanisms, evidence and approach to the problems.
    Horiuchi H
    Ann Med; 2006; 38(3):162-72. PubMed ID: 16720431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.